Progress against Prions

Ideas for treating the human form of mad cow disease begin to emerge

Join Our Community of Science Lovers!


On supporting science journalism

If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today.


More than 200 cases of variant Creutzfeldt-Jakob disease, the human form of mad cow, have occurred worldwide since the 1990s. No accepted treatment exists for the devastatingly fatal disease or any of the others caused by infection with the malformed, malignant protein particles called prions. Giovanna R. Mallucci and her co-workers at the Institute of Neurology in London have performed an experiment in mice that could lay the groundwork for an eventual cure. Researchers genetically engineered mice to produce the protein PrP for only the first nine weeks after birth. PrP misfolds in the presence of prions, which causes it to produce more prions.

When both the altered mice and a normal group were injected with prions causing the illness called scrapie, both groups experienced a cognitive decline at first. The normal subjects continued to deteriorate. But by 12 weeks, the engineered group, without an ongoing supply of PrP, had recovered memory and normal behavior patterns. The absence of the natural protein did not appear to have an adverse effect on the restored rodents. If this approach proves itself further, it might lead to drugs or gene therapies that diminish PrP.

Until that happens, the possibility of prions infecting people through the blood supply remains an ever present fear. Robert Rohwer of the Veterans Affairs Medical Center in Baltimore and his colleagues invented a filter that might be able to purge red blood cells of prions. The team members began by searching through a library of millions of chemicals until they discovered a compound, L13, that readily sticks to prions. Scrapie-containing blood filtered through beads coated with L13 and then injected into hamsters did not cause disease in the animals, unlike tainted, unfiltered blood.

Gary Stix is the former senior editor of mind and brain topics at Scientific American.

More by Gary Stix
Scientific American Magazine Vol 298 Issue 1This article was published with the title “Progress against Prions” in Scientific American Magazine Vol. 298 No. 1 (), p. 50
doi:10.1038/scientificamerican0108-50a

It’s Time to Stand Up for Science

If you enjoyed this article, I’d like to ask for your support. Scientific American has served as an advocate for science and industry for 180 years, and right now may be the most critical moment in that two-century history.

I’ve been a Scientific American subscriber since I was 12 years old, and it helped shape the way I look at the world. SciAm always educates and delights me, and inspires a sense of awe for our vast, beautiful universe. I hope it does that for you, too.

If you subscribe to Scientific American, you help ensure that our coverage is centered on meaningful research and discovery; that we have the resources to report on the decisions that threaten labs across the U.S.; and that we support both budding and working scientists at a time when the value of science itself too often goes unrecognized.

In return, you get essential news, captivating podcasts, brilliant infographics, can't-miss newsletters, must-watch videos, challenging games, and the science world's best writing and reporting. You can even gift someone a subscription.

There has never been a more important time for us to stand up and show why science matters. I hope you’ll support us in that mission.

Thank you,

David M. Ewalt, Editor in Chief, Scientific American

Subscribe